An SNP in the FGFR4 transmembrane region (rs351855), which involves the substitution of a glycine (G) into an arginine (R), has been associated with a poor prognosis in solid tumors, including breast cancer [62]. This evidence concerns the gene FGFR4 and breast cancer.